Accuracy of contrast-enhanced spectral mammography for estimating residual tumor size after neoadjuvant chemotherapy in patients with breast cancer: a feasibility study

Acurácia da mamografia espectral com contraste para seguimento de tumor residual pós-quimioterapia neoadjuvante em pacientes com câncer de mama: um estudo de viabilidade

Filipe Ramos Barra¹; Fernanda Freire de Souza¹; Rosimara Eva Ferreira Almeida Camelo¹; Andrea Campos de Oliveira Ribeiro¹; Luciano Farage²

• Article
• About the authors
• Statistics
• Comments
• Related content

This work is licensed under an Attribution 4.0 International License (CC BY 4.0), effective June 9, 2022. Previously, the journal was licensed under a Creative Commons Attribution - Non-Commercial - Share Alike 4.0 International License.